Medtronic launches DCB clinical trial for below-the-knee peripheral artery disease

Medtronic (NYSE:MDT) said today that it launched a clinical trial to evaluate the use of its In.Pact paclitaxel-coated percutaneous transluminal angioplasty balloon catheter in patients with below-the-knee peripheral arterial disease.

The company treated its 1st patient in the In.Pact BTK study, performing the procedure on a patient with critical limb ischemia.

Get the full story at our sister site, Drug Delivery Business News.

The post Medtronic launches DCB clinical trial for below-the-knee peripheral artery disease appeared first on MassDevice.

from MassDevice http://ift.tt/2mFbDzv